ARWR
Arrowhead Pharmaceuticals Inc
Price:  
22.14 
USD
Volume:  
1,405,142.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ARWR WACC - Weighted Average Cost of Capital

The WACC of Arrowhead Pharmaceuticals Inc (ARWR) is 7.8%.

The Cost of Equity of Arrowhead Pharmaceuticals Inc (ARWR) is 8.25%.
The Cost of Debt of Arrowhead Pharmaceuticals Inc (ARWR) is 5.00%.

Range Selected
Cost of equity 7.20% - 9.30% 8.25%
Tax rate 0.30% - 0.80% 0.55%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.9% - 8.8% 7.8%
WACC

ARWR WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.72 0.79
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.20% 9.30%
Tax rate 0.30% 0.80%
Debt/Equity ratio 0.13 0.13
Cost of debt 5.00% 5.00%
After-tax WACC 6.9% 8.8%
Selected WACC 7.8%